Universal Health Services, Inc.
UHS NYSEHealthcare ★★★★★Latest Earnings
Date
Jul 27, 2026
ET
EPS Est.
5.94
EPS Actual
5.98
Revenue Est.
$4.58B
Revenue Actual
$4.64B
Next Earnings Report
Date
Oct 26, 2026 · Mon
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
5.28
Revenue Est.
$4.72B
Company Overview
Universal Health Services, Inc. (ticker UHS) is listed on NYSE with a market cap of about $10.73B. Its next earnings report (FY2026 Q3) is expected on Oct 26, 2026 (ET), After-market, with consensus EPS of 5.28. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 27, 2023 → Jul 27, 2026
Feb 27, 2023Range: 2.34 ~ 5.98Jul 27, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 27, 2026 | -- | 5.94 | 5.98 | $4.58B | $4.64B |
| Apr 27, 2026 | -- | 5.41 | 5.62 | $4.39B | $4.5B |
| Feb 25, 2026 | -- | 5.92 | 5.88 | $4.5B | $4.49B |
| Oct 27, 2025 | -- | 4.66 | Above forecast↑5.69 | $4.5B | $4.5B |
| Jul 28, 2025 | -- | 4.92 | 5.35 | $4.24B | $4.28B |
| Apr 28, 2025 | -- | 4.35 | 4.84 | $4.15B | $4.1B |
| Feb 26, 2025 | -- | 4.21 | Above forecast↑4.92 | $4.01B | $4.11B |
| Oct 24, 2024 | -- | 3.65 | 3.71 | $4.01B | $3.96B |
| Jul 24, 2024 | -- | 3.28 | Above forecast↑4.31 | $3.87B | $3.91B |
| Apr 24, 2024 | -- | 3.15 | Above forecast↑3.70 | $3.78B | $3.84B |
| Feb 27, 2024 | -- | 2.88 | 3.13 | $3.66B | $3.7B |
| Oct 25, 2023 | -- | 2.36 | 2.55 | $3.67B | $3.56B |
| Jul 25, 2023 | -- | 2.43 | 2.53 | $3.53B | $3.55B |
| Apr 25, 2023 | -- | 2.19 | 2.34 | $3.5B | $3.47B |
| Feb 27, 2023 | -- | 2.96 | 3.02 | $3.4B | $3.45B |
Original Filings (SEC)
8-K2026-08-21 ↗
8-K2026-08-17 ↗
8-K2026-08-13 ↗
10-Q2026-08-07 ↗
8-K2026-07-28 ↗
8-K2026-07-21 ↗
8-K2026-05-22 ↗
8-K2026-05-21 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
